Implanon NXT, 68 mg, implant for subdermal use (etonogestrel) – Extension of use to allow insertion immediately postpartum and immediately postabortion
01/05/2024
Medicines for human use
Product information update (PIU)
This update is to inform healthcare professionals of a recent update to the product information for Implanon NXT, 68mg implant for subdermal use (etonogestrel). This update relates to extending the use of Implanon NXT to allow insertion immediately postpartum (IPP) and immediately postabortion (IPA).
Please see the document linked below for further information.
Product information
- Active substance
- Etonogestrel
- Authorisation holder
- Organon Pharma (Ireland) Limited
- Authorisation number
- PA23198/017/001
- Human or veterinary medicine
- Human Medicine